Rethinking the evaluation of intra-articular drug delivery systems for osteoarthritis

Qing Yao; Yuzhi Zhang; Ruijie Chen

doi:10.1080/17425247.2026.2693498

June 19, 2026Expert Opinion on Drug Delivery

Rethinking the evaluation of intra-articular drug delivery systems for osteoarthritis

View Full Paper

Ask AI

Bookmark

Share

Key Points

The aim is to reassess the effectiveness of intra-articular drug delivery systems for treating osteoarthritis.
Review of various drug delivery systems including liposomes, nanoparticles, and hydrogels.
Analysis of recent advancements in intra-articular therapies.
Comparison of efficacy and safety across different formulations.
Increased awareness of the potential benefits of advanced drug delivery systems in managing osteoarthritis.
Novel drug delivery mechanisms showed enhanced bioavailability and localized treatment effects.
Emerging systems demonstrated potential to improve patient outcomes and reduce systemic side effects.

Implication

Rethinking drug delivery methods in osteoarthritis, suggesting improved therapeutic outcomes.

Abstract

Intra-articular (IA) drug delivery for osteoarthritis (OA) has expanded rapidly in recent years [1,2]. Liposomes, polymeric nanoparticles, microspheres, hydrogels, hybrid systems, and, more rece...

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Yao et al. (2026) studied this question.

synapsesocial.com/papers/6a37805e24f042ddf4c5a801 https://doi.org/10.1080/17425247.2026.2693498

View Full Paper

Ask AI

Bookmark

Share

Rethinking the evaluation of intra-articular drug delivery systems for osteoarthritis

Key Points

Implication

Abstract

Discussion

Cite This Study

Rethinking the evaluation of intra-articular drug delivery systems for osteoarthritis

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading